Home / Drug shortages / Iron Sucrose Injection

Iron Sucrose Injection — FDA Drug Shortage

To Be Discontinued — Mylan Institutional, a Viatris Company

The FDA lists a drug shortage record for Iron Sucrose Injection (injection) from Mylan Institutional, a Viatris Company with status To Be Discontinued. The shortage was first posted on 05/21/2026.

Shortage Details

Status
To Be Discontinued
Company
Mylan Institutional, a Viatris Company
Package NDC
67457-957-99
Dosage Form
Injection
Presentation
Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99)
Initial Posting
05/21/2026
Revised Date

FDA data resources